FEB 25 2004
510(K) SUMMARY OF SAFETY AND EFFECTIVENESS:
Stryker Leibinger Colorado MicroDissection Needle®
Ko 33Q°
General Information K 3 2 3 oe
Proprietary Name: Stryker Leibinger Colorado MicroDissection
Needle®
Common Name: Electrode, Electrosurgical
Proposed Regulatory Class: Class II
Device Classification: GEI
878.4400, Electrosurgical Electrode
Submitter: Stryker Leibinger
4100 East Milham Avenue
Kalamazoo, MI 49001
269-323-4226
Submitter’s Registration #: 1811755
Manufacturer’s Registration #: 9616696
Contact Person: Wade T. Rutkoskie
Associate Manager RA QA
Phone: 269-323-4226
Fax: 269-323-4215
Intended Use
The Colorado MicroDissection Needle® is a monopolar electrosurgical instrument used for
precision soft tissue dissection. Including but not limited to tonsillectomy and blepharoplasty. It
is a single-use device intended for cutting, dissecting and cauterizing soft tissue. The Colorado
MicroDissection Needle is not intended for use in the central nervous system or in the central
circulatory system.
Substantial Equivalence
EQUIVALENT PRODUCTS:
The Stryker Colorado MicroDissection Needle is equivalent to the previous version of the
product cleared under K000348, and the product manufactured by Colorado Biomedical,
] and ‘eh ti hil Equivalent product information is found in Appendix 3.
Wade T. Rutkoskie
Associate Manager RA QA
Stryker Instruments
Leibinger Division

ey
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
LE
on Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
FEB 25 2004
Mr. Wade T. Rutkoskie
Associate Manager RA, QA
Stryker Leibinger
4100 East Milham Avenuc
Kalamazoo, Michigan 49001
Re: K033232
‘Trade/Device Name: Stryker Leibinger Colorado MicroDissection Needle®
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessorics
Regulatory Class: If
Product Code: GEI
Dated: December 9, 2003
Received: December 10, 2003
Dear Mr. Rutkoskic:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10
devices that have been reclassified in accordance with the provisions of the l’ederal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requiremenis for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class 1] (Special Controls) or class Til (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Wade T. Rutkoskie
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CER Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda. gov/cdrh/dsma/dsmamain.html

Sincerely yours,

ao

Y howe

Celia M, Witten, Ph.D., M.D.

Director

Division of General, Restorative

and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure :

Page 1 of 1
510(K) Number (if known): kK 0232 Sade
Device Name: Colorado MicroDissection Needle®
Intended Use:
The Colorado MicroDissection Needle® is a monopolar electrosurgical instrument
used for precision soft tissue dissection. Including but not limited to
tonsillectomy and blepharoplasty. It is a single-use device intended for cutting,
dissecting and cauterizing soft tissue. The Colorado MicroDissection Needle is
not intended for use in the central nervous system or in the central circulatory
system.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE
IF NEEDED)
—___ —_—_ ie
Concurrence of CDRH, Office of Dev EvalpatigQODE)
(Divisio Sign-Off) tive
Division of General, Restorative,
and New2stogical Devices
L033 23>
a 510(k) Naiber_—————~
Prescription Use \ or Over-The-Counter Use
(per 21 CFR 801.109)
(Optional Format 1-2-96)

